GE HealthCare backs FY26 adjusted EPS view $4.95-$5.15, consensus $5.06

For FY26: Organic revenue growth of 3.0% to 4.0% year-over-year; unchanged; Adjusted EBIT margin of 15.4% to 15.7%, reflecting an expansion of 10 bps to 40 bps year-over-year; this compares to previous Adjusted EBIT margin guidance of 15.8% to 16.1%; Adjusted effective tax rate in the range of 20.0% to 21.0%; unchanged. Free cash flow* of approximately $1.6 billion, in-line with profit outlook; this compares to previous guidance of approximately $1.7 billion. Expects tariff impact in 2026 to be lower than 2025. While the Company has begun to apply for refunds in the new Customs and Border Patrol portal, no International Emergency Economic Powers Act tariff refund is assumed in guidance. Guidance includes contribution from Intelerad as of March 18, 2026.